Promazine
Promazine (brand name Sparine) is a medication that belongs to the phenothiazine class of antipsychotics. An older medication used to treat schizophrenia, it is still prescribed, alongside newer agents such as olanzapine and quetiapine. It has predominantly anticholinergic side effects, though extrapyramidal side effects are not uncommon either.
Not to be confused with Bromazine.
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a600010 |
ATC code | |
Pharmacokinetic data | |
Protein binding | 94% |
Elimination half-life | 20-40 hr |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.347 |
Chemical and physical data | |
Formula | C17H20N2S |
Molar mass | 284.42 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Promazine has been approved for human use in the United States, although it has been discontinued.[1] It is available in the US for veterinary use under the names Promazine and Tranquazine.
References
Typical |
|
---|---|
Disputed | |
Atypical |
|
Others | |
|
Classes |
|
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.